KLEANTHIS G XANTHOPOULOS Insider Trading $RGLS Regulus Therapeutics Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KLEANTHIS G XANTHOPOULOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KLEANTHIS G XANTHOPOULOS. KLEANTHIS G XANTHOPOULOS is Director in APRICUS BIOSCIENCES, INC. ($APRI) and President and CEO in Regulus Therapeutics Inc. ($RGLS) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN).
KLEANTHIS G XANTHOPOULOS in Regulus Therapeutics Inc.
Trading Symbol: RGLSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KLEANTHIS G XANTHOPOULOS: President and CEO
Holdings: 3,705 shares
Current Value: $5,187
Latest Transaction: Apr 21 2015
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KLEANTHIS G XANTHOPOULOS in Regulus Therapeutics Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, RGLS, SEEL, ZSAN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 60,000 | 22,800 | 8,287 | |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 66,071 | 25,107 | 68,287 | |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 73,929 | 28,093 | 134,358 | |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 17.73 | 60,000 | 1,063,980 | 3,705 | 63.7 K to 3.7 K (-94.18 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 60,000 | 22,800 | 63,705 | 3.7 K to 63.7 K (+1,619.43 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 16.85 | 66,071 | 1,113,514 | 3,705 | 69.8 K to 3.7 K (-94.69 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 66,071 | 25,107 | 69,776 | 3.7 K to 69.8 K (+1,783.29 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 16.94 | 73,929 | 1,252,002 | 3,705 | 77.6 K to 3.7 K (-95.23 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 73,929 | 28,093 | 77,634 | 3.7 K to 77.6 K (+1,995.38 %) |
Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 89,230 | 33,907 | 208,287 | |
Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 20.81 | 23,616 | 491,551 | 2,466 | 26.1 K to 2.5 K (-90.55 %) |
Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 20.06 | 65,614 | 1,316,512 | 26,082 | 91.7 K to 26.1 K (-71.56 %) |
Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 89,230 | 33,907 | 91,696 | 2.5 K to 91.7 K (+3,618.41 %) |
Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 70 | 27 | 297,517 | |
Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 19.50 | 70 | 1,365 | 2,466 | 2.5 K to 2.5 K (-2.76 %) |
Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 70 | 27 | 2,536 | 2.5 K to 2.5 K (+2.84 %) |
Page: 1